NEUP Neuphoria Therapeutics Inc. - Common Stock
$4.81
价格 · 五月 20, 2026
截至...的财报数据 五月 15, 2026
52周区间
$4–$21
7% of range
分析师评级
BUY
9 analysts
目标价
$7
+46% upside
P/E (TTM)
-30.9
ROE
-2.3%
净利润率
-2.4%
NEUP 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$4.80
市值
$14M
P/E (TTM)
-30.9
每股收益 (TTM)
$-0.23
营收 (TTM)
$16M
股息收益率
—
ROE
-2.3%
负债/权益
—
52周区间
$4 – $21
NEUP 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$16M
2025-06-30
→
2025-06-30
EPS
$-0.23
2023-06-30
→
2025-06-30
自由现金流
—
利润率
-2.4%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
NEUP
同行中位数
P/E (TTM)
-30.9
0.1
P/S (TTM) (市销率 (TTM))
0.9
64.9
P/B (市净率)
0.7
1.7
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
NEUP
同行中位数
Operating Margin (营业利润率)
-7.2%
—
Net Profit Margin (净利润率)
-2.4%
-127.5%
ROA
-1.3%
-70.0%
ROE
-2.3%
-143.6%
ROIC
-2.6%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
NEUP
同行中位数
Current Ratio (流动比率)
3.6
3.3
Quick Ratio (速动比率)
3.4
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
NEUP
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
NEUP
同行中位数
NEUP 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
9 位分析师
- 强烈买入 2 22.2%
- 买入 5 55.6%
- 持有 2 22.2%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
1 位分析师 · 2026-05-17
最低
$7.00
最高
$7.00
中位数目标
$7.00
+45.7%
平均目标
$7.00
+45.7%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-1.3%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年9月30日 | $-0.09 | $-0.99 | — |
| 2026年3月31日 | $-0.09 | $-0.99 | 0.90% |
| 2025年12月31日 | $-0.77 | $-1.49 | 0.72% |
| 2025年9月30日 | $-4.41 | $-1.35 | -3.1% |
| 2025年6月30日 | $-5.79 | $-2.12 | -3.7% |
同行比较 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| NEUP | $14M | -30.9 | — | -2.4% | -2.3% | — |
| PPCB | $48M | -0.3 | — | — | -1209.0% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 15
| 指标 | 趋势 | 2025 |
|---|---|---|
| Revenue | $16M | |
| R&D Expense | $9M | |
| SG&A Expense | $8M | |
| Operating Expenses | $17M | |
| Operating Income | $-1M | |
| Interest Income | $166.5K | |
| Other Non-op | $291.1K | |
| Pretax Income | $-838.0K | |
| Income Tax | $-468.4K | |
| Net Income | $-400.0K | |
| EPS (Basic) | $-0.23 | |
| EPS (Diluted) | $-0.23 | |
| Shares (Basic) | 1,622,924 | |
| Shares (Diluted) | 1,622,924 | |
| EBITDA | $-1M |
资产负债表 19
| 指标 | 趋势 | 2025 |
|---|---|---|
| Cash & Equivalents | $14M | |
| Receivables | $11.9K | |
| Prepaid Expense | $740.2K | |
| Current Assets | $15M | |
| PP&E (Net) | $2.8K | |
| Goodwill | $9M | |
| Intangibles | $5M | |
| Total Assets | $29M | |
| Accounts Payable | $1M | |
| Current Liabilities | $4M | |
| Deferred Tax | $495.1K | |
| Total Liabilities | $10M | |
| Common Stock | $19 | |
| Paid-in Capital | $200M | |
| Retained Earnings | $-178M | |
| AOCI | $-3M | |
| Stockholders' Equity | $19M | |
| Liabilities + Equity | $29M | |
| Shares Outstanding | 1,978,460 |
现金流 8
| 指标 | 趋势 | 2025 |
|---|---|---|
| D&A | $662.9K | |
| Stock-based Comp | $163.8K | |
| Deferred Tax | $-468.4K | |
| Operating Cash Flow | $77.2K | |
| Stock Issued | $2M | |
| Net Stock Activity | $2M | |
| Financing Cash Flow | $2M | |
| Net Change in Cash | $2M |
盈利能力 7
| 指标 | 趋势 | 2025 |
|---|---|---|
| Operating Margin | -7.2% | |
| Net Margin | -2.4% | |
| Pretax Margin | -5.3% | |
| EBITDA Margin | -7.2% | |
| ROA | -1.3% | |
| ROE | -2.3% | |
| ROIC | -2.6% |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 |
|---|---|---|
| Current Ratio | 3.6 | |
| Quick Ratio | 3.4 |
效率 2
| 指标 | 趋势 | 2025 |
|---|---|---|
| Asset Turnover | 0.6 | |
| Receivables Turnover | 225.4 |
估值 (TTM) 9
| 指标 | 趋势 | 2025 |
|---|---|---|
| Revenue TTM | $16M | |
| Net Income TTM | $-400.0K | |
| Market Cap | $14M | |
| P/E | -30.9 | |
| P/S | 0.9 | |
| P/B | 0.7 | |
| P / Tangible Book | 2.5 | |
| P / Cash Flow | 181.9 | |
| Earnings Yield | -3.2% |
损益表 15
| 指标 | 趋势 | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $-13.3K | $15M | $662.7K | |
| R&D Expense | · | $697.7K | $4M | $4M | $2M | $2M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $1M | $3M | |
| Operating Expenses | $1M | $4M | $6M | $6M | $3M | $4M | |
| Operating Income | $-1M | $-4M | $-6M | $-6M | $12M | $-4M | |
| Interest Income | $186.2K | $167.3K | $142.0K | $87.0K | $12.7K | $30.6K | |
| Other Non-op | $671.8K | $6M | $-4M | $-3M | $-796.2K | $2M | |
| Pretax Income | $-539.9K | $2M | $-10M | $-9M | $11M | $-2M | |
| Income Tax | $-34.8K | $-34.8K | $-34.8K | $-266.6K | $-81.2K | $11.6K | |
| Net Income | $-505.1K | $2M | $-10M | $-9M | $11M | $-2M | |
| EPS (Basic) | $-0.09 | $0.41 | $-4.41 | $-4.93 | $6.55 | $-1.23 | |
| EPS (Diluted) | $-0.09 | $-0.77 | $-4.41 | $-4.37 | $6.55 | $-1.79 | |
| Shares (Basic) | 5,411,244 | 4,536,235 | 2,246,066 | -2,971,458 | 1,719,073 | 1,575,244 | |
| Shares (Diluted) | 5,411,244 | 4,536,235 | 2,246,066 | -2,971,458 | 1,719,073 | 1,575,244 | |
| EBITDA | $-1M | $-4M | $-6M | · | $12M | $-4M |
资产负债表 21
| 指标 | 趋势 | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $22M | $14M | $14M | $17M | $4M | |
| Receivables | $2M | $1M | $1.8K | $11.9K | $24.6K | $35.6K | |
| Prepaid Expense | $611.9K | $27.0K | $222.3K | $740.2K | $20.9K | $18.5K | |
| Current Assets | $22M | $23M | $14M | $15M | $17M | $4M | |
| PP&E (Net) | · | · | $2.6K | $2.8K | $1.6K | $1.7K | |
| Goodwill | $9M | $9M | $9M | $9M | $8M | $8M | |
| Intangibles | $4M | $4M | $5M | $5M | $5M | $5M | |
| Total Assets | $35M | $37M | $27M | $29M | $31M | $18M | |
| Accounts Payable | $627.2K | $520.7K | $1M | $1M | $745.3K | $2M | |
| Current Liabilities | $2M | $3M | $5M | $4M | $2M | $2M | |
| Capital Leases | · | · | · | · | $19.3K | $49.8K | |
| Deferred Tax | $390.7K | $425.5K | $460.3K | $495.1K | $761.7K | $842.9K | |
| Other Non-current Liabilities | · | · | · | · | $3.6K | $3.4K | |
| Total Liabilities | $5M | $7M | $15M | $10M | $5M | $4M | |
| Common Stock | $54 | $54 | $23 | $19 | $19 | $16 | |
| Paid-in Capital | $218M | $218M | $204M | $200M | $199M | $198M | |
| Retained Earnings | $-187M | $-186M | $-188M | $-178M | $-169M | $-181M | |
| AOCI | $-2M | $-2M | $-3M | $-3M | $-4M | $-4M | |
| Stockholders' Equity | $29M | $30M | $13M | $19M | $26M | $14M | |
| Liabilities + Equity | $35M | $37M | $27M | $29M | $31M | $18M | |
| Shares Outstanding | 5,377,329 | 5,377,329 | 2,357,613 | 1,978,460 | 1,853,966 | 1,628,659 |
现金流 8
| 指标 | 趋势 | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 |
|---|---|---|---|---|---|---|---|
| D&A | $165.7K | $165.8K | $165.8K | $165.6K | $165.4K | $166.1K | |
| Stock-based Comp | $70.3K | $93.7K | $111.3K | $98.3K | $19.7K | $19.1K | |
| Restructuring | $42.4K | $1M | · | · | · | · | |
| Operating Cash Flow | $-3M | $-6M | $-4M | $-4M | $11M | $-3M | |
| Stock Issued | $0 | $15M | $3M | $704.7K | $823.6K | $0 | |
| Net Stock Activity | · | · | $3M | · | · | · | |
| Financing Cash Flow | $0 | $15M | $3M | $704.7K | $1M | $-111.6K | |
| Net Change in Cash | $-3M | $9M | $-560.5K | $-3M | $13M | $-4M |
盈利能力 7
| 指标 | 趋势 | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | 79.8% | -558.8% | |
| Net Margin | · | · | · | · | 75.1% | -293.2% | |
| Pretax Margin | · | · | · | · | 74.5% | -291.5% | |
| EBITDA Margin | · | · | · | · | 79.8% | -558.8% | |
| ROA | -1.5% | 6.8% | -39.4% | · | 73.3% | -21.4% | |
| ROE | -1.8% | 8.6% | -67.0% | · | 86.6% | -28.3% | |
| ROIC | -3.9% | -13.9% | -45.0% | · | 46.4% | -27.1% |
流动性与偿付能力 2
| 指标 | 趋势 | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 14.3 | 9.0 | 2.7 | · | 11.0 | 2.1 | |
| Quick Ratio | 13.9 | 9.0 | 2.7 | · | 11.0 | 2.1 |
效率 2
| 指标 | 趋势 | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 1.0 | 0.1 | |
| Receivables Turnover | · | · | · | · | 1219.9 | 37.3 |
估值 (TTM) 7
| 指标 | 趋势 | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2024 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $3M | $1M | $-1M | · | $6M | $-10M | |
| Market Cap | $22M | $21M | $28M | · | $11M | $6M | |
| P/E | 3.2 | -9.2 | -43.7 | · | 4.4 | -0.3 | |
| P/B | 0.7 | 0.7 | 2.2 | · | 0.4 | 0.4 | |
| P / Tangible Book | 1.3 | 1.3 | · | · | 0.8 | 27.3 | |
| P / Cash Flow | · | · | -7.3 | · | · | · | |
| Earnings Yield | 31.4% | -10.8% | -2.3% | · | 22.7% | -307.6% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-06-30 | 2024-06-30 | 2023-06-30 | |
|---|---|---|---|
| 收入 | $16M | — | — |
| 营业利润率 % | -7.2% | — | — |
| 净收入 | $-400.0K | $-15M | $-21M |
| 稀释后每股收益 (EPS) | $-0.23 | $-18.62 | $-0.02 |
资产负债表
| 2025-06-30 | 2024-06-30 | 2023-06-30 | |
|---|---|---|---|
| 流动比率 | 3.6 | 3.4 | — |
| 速动比率 | 3.4 | 3.3 | — |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。